NEUP
Price
$7.20
Change
-$0.22 (-2.96%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
13.97M
SLGL
Price
$16.36
Change
+$0.37 (+2.31%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
44.54M
Earnings call today
Interact to see
Advertisement

NEUP vs SLGL

Header iconNEUP vs SLGL Comparison
Open Charts NEUP vs SLGLBanner chart's image
Neuphoria Therapeutics
Price$7.20
Change-$0.22 (-2.96%)
Volume$285
Capitalization13.97M
Sol-Gel Technologies
Price$16.36
Change+$0.37 (+2.31%)
VolumeN/A
Capitalization44.54M
NEUP vs SLGL Comparison Chart in %
Loading...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEUP vs. SLGL commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEUP is a Hold and SLGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (NEUP: $7.42 vs. SLGL: $15.99)
Brand notoriety: NEUP and SLGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NEUP: 66% vs. SLGL: 88%
Market capitalization -- NEUP: $13.97M vs. SLGL: $44.54M
NEUP [@Biotechnology] is valued at $13.97M. SLGL’s [@Biotechnology] market capitalization is $44.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEUP’s FA Score shows that 1 FA rating(s) are green whileSLGL’s FA Score has 0 green FA rating(s).

  • NEUP’s FA Score: 1 green, 4 red.
  • SLGL’s FA Score: 0 green, 5 red.
According to our system of comparison, NEUP is a better buy in the long-term than SLGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEUP’s TA Score shows that 3 TA indicator(s) are bullish while SLGL’s TA Score has 6 bullish TA indicator(s).

  • NEUP’s TA Score: 3 bullish, 5 bearish.
  • SLGL’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SLGL is a better buy in the short-term than NEUP.

Price Growth

NEUP (@Biotechnology) experienced а -7.83% price change this week, while SLGL (@Biotechnology) price change was +23.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

SLGL is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLGL($44.5M) has a higher market cap than NEUP($14M). NEUP YTD gains are higher at: 116.327 vs. SLGL (71.917). NEUP has higher annual earnings (EBITDA): 192K vs. SLGL (-9.66M). NEUP (17M) and SLGL (16.9M) have equal amount of cash in the bank . NEUP has less debt than SLGL: NEUP (172K) vs SLGL (1.18M). NEUP has higher revenues than SLGL: NEUP (15.7M) vs SLGL (12.1M).
NEUPSLGLNEUP / SLGL
Capitalization14M44.5M31%
EBITDA192K-9.66M-2%
Gain YTD116.32771.917162%
P/E Ratio0.39N/A-
Revenue15.7M12.1M130%
Total Cash17M16.9M101%
Total Debt172K1.18M15%
FUNDAMENTALS RATINGS
SLGL: Fundamental Ratings
SLGL
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NEUPSLGL
RSI
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 15 days ago
89%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HPAI3.950.10
+2.60%
Helport AI Limited
ADM57.84-0.02
-0.03%
Archer Daniels Midland Company
ASO49.63-0.57
-1.14%
Academy Sports and Outdoors
ADTN8.59-0.12
-1.38%
ADTRAN Holdings
MRKR1.19-0.04
-3.25%
Marker Therapeutics

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with QLGN. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then QLGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
-4.26%
QLGN - NEUP
61%
Loosely correlated
-1.62%
SLGL - NEUP
42%
Loosely correlated
+9.45%
CMND - NEUP
34%
Loosely correlated
-3.24%
MNPR - NEUP
25%
Poorly correlated
-9.61%
PPBT - NEUP
25%
Poorly correlated
-0.93%
More

SLGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLGL has been loosely correlated with TRAW. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SLGL jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLGL
1D Price
Change %
SLGL100%
+9.45%
TRAW - SLGL
47%
Loosely correlated
+1.35%
NEUP - SLGL
42%
Loosely correlated
-4.26%
RAPT - SLGL
39%
Loosely correlated
-3.12%
AZTR - SLGL
33%
Poorly correlated
-2.32%
GTBP - SLGL
33%
Poorly correlated
+2.87%
More